I had not planned to write a post about the novel corona virus disease 2019 (COVID-19). What could I add to this conversation? Update: Visit the Center for Disease Control for current information and advice about Covid-19. After all, I am not a doctor. I am not a nurse. I am not a public health …
In the news
As an advocate and someone personally impacted by genetic testing in a huge way, I read with great interest the announcement from the American Society of Breast Surgeons that Dr. Deanna Attai shared about in a recent blog post titled, Updated Breast Cancer Genetic Testing Guidelines. Read the guidelines in full here. They are worth a …
What does the American public really know about cancer? According to the second annual National Cancer Opinion Survey, maybe not as much as we all might think. The survey was commissioned by the American Society of Clinical Oncology (ASCO). It was conducted by The Harris Poll this past summer, and the results may or may …
After the shooting at Marjory Stoneman Douglas High School in Parkland, Florida, the tweets and Facebook posts started flying. Lots of thoughts and prayers were offered. Mere days later, some of those kids who survived that horrific event, were on TV talking about how thoughts and prayers are no longer enough. They never were.
The recent announcement by 23andMe, stating it now has FDA authorization to report on three specific BRCA1 and BRCA2 breast cancer gene mutations associated with breast, ovarian and prostate cancer via direct-to-consumer (DTC) testing, stirred up debate. Since reading about this announcement, I’ve been mulling over my thoughts on it.